AZMAX
Price
$25.66
Change
+$0.32 (+1.26%)
Updated
Jun 22 closing price
Net Assets
17.91M
RNWBX
Price
$104.88
Change
+$0.54 (+0.52%)
Updated
Jun 22 closing price
Net Assets
90.88B
Interact to see
Advertisement

AZMAX vs RNWBX

AZMAX vs RNWBX Comparison Chart in %
View a ticker or compare two or three
VS
AZMAX vs. RNWBX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZMAX is a StrongBuy and RNWBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 90.9B vs. AZMAX (17.9M). AZMAX pays higher dividends than RNWBX: AZMAX (2.52) vs RNWBX (0.41). AZMAX was incepted earlier than RNWBX: AZMAX (14 years) vs RNWBX (24 years). AZMAX (2.32) is less costly to investors than RNWBX (1.66). AZMAX is a more actively managed with annual turnover of: 74.00 vs. RNWBX (46.00). RNWBX has a lower initial minimum investment than AZMAX: RNWBX (250) vs AZMAX (2500). AZMAX annual gain was more profitable for investors over the last year : 49.60 vs. RNWBX (29.69). AZMAX return over 5 years is better than : 25.50 vs. RNWBX (15.20).
AZMAXRNWBXAZMAX / RNWBX
Total Expense Ratio1.141.6669%
Annual Report Gross Expense Ratio2.321.66140%
Fund Existence14 years24 years-
Gain YTD26.51018.201146%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.9M90.9B0%
Annual Yield % from dividends2.520.41610%
Returns for 1 year49.6029.69167%
Returns for 3 years68.4352.51130%
Returns for 5 years25.5015.20168%
Returns for 10 years131.07122.04107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSNCX60.061.29
+2.19%
Neuberger Small Cap Growth C
OEGIX42.89N/A
N/A
Invesco Discovery Mid Cap Growth R6
AVPEX11.32N/A
N/A
ALPS Global Opportunity Portfolio Cl III
LMORX51.24N/A
N/A
Patient Opportunity R
AIGGX15.72N/A
N/A
Aristotle Growth Equity I-2